Insulet Price to Free Cash Flow Ratio 2010-2025 | PODD
Historical price to free cash flow ratio values for Insulet (PODD) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Insulet Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-22 | 321.00 | 81.47 | |
| 2025-03-31 | 262.61 | $3.94 | 66.65 |
| 2024-12-31 | 261.07 | $4.13 | 63.16 |
| 2024-09-30 | 232.75 | $3.07 | 75.74 |
| 2024-06-30 | 201.80 | $2.58 | 78.18 |
| 2024-03-31 | 171.40 | $1.98 | 86.44 |
| 2023-12-31 | 216.98 | $0.95 | 227.92 |
| 2023-09-30 | 159.49 | $0.54 | 295.79 |
| 2023-06-30 | 288.34 | $0.43 | 666.07 |
| 2023-03-31 | 318.96 | $0.18 | 1764.16 |
| 2022-12-31 | 294.39 | $-0.06 | 0.00 |
| 2022-09-30 | 229.40 | $-0.72 | 0.00 |
| 2022-06-30 | 217.94 | $-1.81 | 0.00 |
| 2022-03-31 | 266.39 | $-1.98 | 0.00 |
| 2021-12-31 | 266.07 | $-2.62 | 0.00 |
| 2021-09-30 | 284.23 | $-2.28 | 0.00 |
| 2021-06-30 | 274.51 | $-1.29 | 0.00 |
| 2021-03-31 | 260.92 | $-1.23 | 0.00 |
| 2020-12-31 | 255.63 | $-0.68 | 0.00 |
| 2020-09-30 | 236.59 | $-0.20 | 0.00 |
| 2020-06-30 | 194.26 | $-0.33 | 0.00 |
| 2020-03-31 | 165.68 | $-0.91 | 0.00 |
| 2019-12-31 | 171.20 | $-1.05 | 0.00 |
| 2019-09-30 | 164.93 | $-1.05 | 0.00 |
| 2019-06-30 | 119.38 | $-1.49 | 0.00 |
| 2019-03-31 | 95.09 | $-1.93 | 0.00 |
| 2018-12-31 | 79.32 | $-1.99 | 0.00 |
| 2018-09-30 | 105.95 | $-2.02 | 0.00 |
| 2018-06-30 | 85.70 | $-1.49 | 0.00 |
| 2018-03-31 | 86.68 | $-0.41 | 0.00 |
| 2017-12-31 | 69.00 | $-0.56 | 0.00 |
| 2017-09-30 | 55.08 | $-0.19 | 0.00 |
| 2017-06-30 | 51.31 | $-0.63 | 0.00 |
| 2017-03-31 | 43.09 | $-0.69 | 0.00 |
| 2016-12-31 | 37.68 | $-0.11 | 0.00 |
| 2016-09-30 | 40.94 | $-0.80 | 0.00 |
| 2016-06-30 | 30.24 | $-0.50 | 0.00 |
| 2016-03-31 | 33.16 | $-0.51 | 0.00 |
| 2015-12-31 | 37.81 | $-0.41 | 0.00 |
| 2015-09-30 | 25.91 | $0.02 | 1599.38 |
| 2015-06-30 | 30.99 | $-0.06 | 0.00 |
| 2015-03-31 | 33.35 | $-0.13 | 0.00 |
| 2014-12-31 | 46.06 | $-0.05 | 0.00 |
| 2014-09-30 | 36.85 | $-0.20 | 0.00 |
| 2014-06-30 | 39.67 | $-0.20 | 0.00 |
| 2014-03-31 | 47.42 | $-0.09 | 0.00 |
| 2013-12-31 | 37.10 | $-0.07 | 0.00 |
| 2013-09-30 | 36.24 | $-0.12 | 0.00 |
| 2013-06-30 | 31.41 | $-0.32 | 0.00 |
| 2013-03-31 | 25.86 | $-0.66 | 0.00 |
| 2012-12-31 | 21.22 | $-0.84 | 0.00 |
| 2012-09-30 | 21.58 | $-0.90 | 0.00 |
| 2012-06-30 | 21.37 | $-0.81 | 0.00 |
| 2012-03-31 | 19.14 | $-0.77 | 0.00 |
| 2011-12-31 | 18.83 | $-0.78 | 0.00 |
| 2011-09-30 | 15.26 | $-0.84 | 0.00 |
| 2011-06-30 | 22.17 | $-1.10 | 0.00 |
| 2011-03-31 | 20.62 | $-1.03 | 0.00 |
| 2010-12-31 | 15.50 | $-1.06 | 0.00 |
| 2010-09-30 | 14.14 | $-1.07 | 0.00 |
| 2010-06-30 | 15.05 | $-1.16 | 0.00 |
| 2010-03-31 | 15.09 | $-1.56 | 0.00 |
| 2009-12-31 | 14.28 | $-1.76 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $22.837B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.485B | 27.83 |
| Boston Scientific (BSX) | United States | $154.809B | 38.76 |
| Stryker (SYK) | United States | $144.946B | 30.31 |
| EssilorLuxottica (ESLOY) | France | $134.105B | 0.00 |
| Medtronic (MDT) | Ireland | $108.260B | 15.35 |
| Haleon (HLN) | United Kingdom | $50.025B | 28.46 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.059B | 0.00 |
| ResMed (RMD) | United States | $36.038B | 27.07 |
| GE HealthCare Technologies (GEHC) | United States | $31.860B | 15.13 |
| Agilent Technologies (A) | United States | $31.051B | 20.51 |
| Terumo (TRUMY) | Japan | $27.450B | 35.65 |
| Koninklijke Philips (PHG) | Netherlands | $22.023B | 15.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.348B | 11.78 |
| Baxter (BAX) | United States | $15.616B | 11.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.578B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.204B | 21.59 |
| Lantheus Holdings (LNTH) | United States | $5.198B | 13.11 |
| Prestige Consumer Healthcare (PBH) | United States | $4.172B | 18.64 |
| Perrigo (PRGO) | Ireland | $3.700B | 9.38 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.362B | 14.64 |
| ICU Medical (ICUI) | United States | $3.218B | 23.73 |
| Envista Holdings (NVST) | United States | $2.820B | 23.44 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| QuidelOrtho (QDEL) | United States | $2.000B | 13.76 |
| LeMaitre Vascular (LMAT) | United States | $1.841B | 41.16 |
| AtriCure (ATRC) | United States | $1.647B | 0.00 |
| Neogen (NEOG) | United States | $1.350B | 17.28 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.223B | 12.41 |
| Kestra Medical Technologies (KMTS) | United States | $1.186B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.169B | 26.29 |
| BioLife Solutions (BLFS) | United States | $1.049B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.05 |
| InMode (INMD) | Israel | $0.898B | 9.05 |
| CeriBell (CBLL) | United States | $0.634B | 0.00 |
| Evolus (EOLS) | United States | $0.618B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Owens & Minor (OMI) | United States | $0.531B | 4.40 |
| Valneva SE (VALN) | France | $0.527B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.508B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.436B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.338B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.315B | 11.58 |
| Aurora Cannabis (ACB) | Canada | $0.293B | 52.20 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.267B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Verano Holdings (VRNOF) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.237B | 10.78 |
| Biote (BTMD) | United States | $0.212B | 5.95 |
| Brainsway (BWAY) | Israel | $0.196B | 52.00 |
| OraSure Technologies (OSUR) | United States | $0.190B | 0.00 |
| Quanterix (QTRX) | United States | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Omeros (OMER) | United States | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.176B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.173B | 14.11 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.07 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Fonar (FONR) | United States | $0.085B | 10.96 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| United Health Products (UEEC) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.44 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 32.29 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |